Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $45 Million Private Placement with Innoviva Mar 31, 2022 04:05PM
Armata Pharma (ARMP) Announces 9M Share Sale to Innoviva (INVA) at $5/sh Feb 9, 2022 04:24PM
Armata Pharmaceuticals Announces $45 Million Investment to Support Advancement of the Company's Bacteriophage Development Feb 9, 2022 04:16PM
Armata Pharmaceuticals to Present at the Ladenburg Thalmann 2021 Healthcare Conference Jul 7, 2021 07:30AM
Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $20 Million Private Placement with Innoviva Mar 17, 2021 04:01PM


Jan 27, 2021 07:01AM Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs
Jan 28, 2020 07:04AM Innoviva (INVA) to purchase approximately $25 million in Armata (ARMP) common stock and warrants
Jan 28, 2020 07:00AM Armata Pharmaceuticals and Innoviva Announce $25 Million Strategic Investment to Support Advancement of Armata's Bacteriophage Development Programs
Nov 12, 2019 04:05PM Armata Pharmaceuticals Announces Third Quarter Results and Provides Corporate and Clinical Update
Sep 19, 2019 07:05AM Armata Pharmaceuticals to Participate in the Ladenburg Thalmann 2019 Healthcare Conference
Aug 14, 2019 04:05PM Armata Pharmaceuticals Announces Second Quarter Results and Provides Corporate and Clinical Update
Jun 19, 2019 06:38AM Ladenburg Thalmann Starts Armata Pharmaceuticals (ARMP) at Buy
May 9, 2019 04:01PM C3J Therapeutics and AmpliPhi Biosciences Announce Successful Completion of Merger and Formation of Bacteriophage Company Armata Pharmaceuticals, Inc.